London South Bank University, London, UK.
Walthamstow Drug Services, London, UK.
Addict Behav. 2018 Feb;77:210-216. doi: 10.1016/j.addbeh.2017.10.013. Epub 2017 Oct 18.
To analyse predictors of heroin abstinence in opiate substitution therapy (OST) based on frequency of crack use and its interactions with other predictors in a clinical non-experimental setting.
Retrospective study.
A community drug service in London, UK.
325 clients starting OST between 2010 and 2014 (197 methadone and 128 buprenorphine).
Logistic regression models (a general model and separate models for methadone and buprenorphine) assessed demographic and clinical data as predictors of heroin abstinence at one year after treatment start (or at the date of transfer to another service).
For the general model participants choosing methadone were more likely to use heroin at follow up (OR=2.36, 95% CI: 1.40-3.17) as were daily crack users on methadone (OR=2.62, 95% CI: 0.96-7.16). For the methadone model only daily crack use predicted heroin use at follow up (OR=2.62, 95% CI: 0.96-7.16). For buprenorphine, higher amounts of baseline heroin use, lower buprenorphine dose and daily drinking predicted heroin use at follow up (OR=0.85, 95% CI: 0.75-0.95; OR=1.31, 95% CI: 1.06-1.60 and OR=6.04, 95% CI: 1.26-28.92). Both use of cannabis and depression increased likelihood of heroin abstinence for clients not using crack compared to occasional (OR=6.68, 95% CI: 0.37-119.59; OR=106.31, 95% CI: 3.41-3313.30) and daily (OR=57.49 (95% CI: 2.37-1396.46; OR=170.99 (95% CI: 4.61-6339.47) users.
Most of the predictors in the general model were found significant only in the buprenorphine but not in the methadone model, suggesting that a general model has little predictive value. Crack use was a significant predictor of heroin abstinence at follow up in all models, however for buprenorphine only when depression or cannabis use was present. Further research is needed to assess effective treatment approaches for the growing population of dual users.
在非实验性临床环境中,基于可卡因使用频率及其与其他预测因子的相互作用,分析阿片类药物替代疗法(OST)中海洛因戒除的预测因子。
回顾性研究。
英国伦敦的一个社区毒品服务机构。
2010 年至 2014 年间开始 OST 的 325 名患者(197 名美沙酮和 128 名丁丙诺啡)。
逻辑回归模型(一般模型和分别针对美沙酮和丁丙诺啡的模型)评估了人口统计学和临床数据作为治疗开始后一年(或转移到另一个服务机构时)海洛因戒除的预测因子。
对于一般模型,选择美沙酮的参与者在随访时更有可能使用海洛因(OR=2.36,95%CI:1.40-3.17),美沙酮每日可卡因使用者也是如此(OR=2.62,95%CI:0.96-7.16)。对于美沙酮模型,只有每日可卡因使用预测了随访时的海洛因使用(OR=2.62,95%CI:0.96-7.16)。对于丁丙诺啡,基线海洛因使用量较高、丁丙诺啡剂量较低和每日饮酒预测了随访时的海洛因使用(OR=0.85,95%CI:0.75-0.95;OR=1.31,95%CI:1.06-1.60 和 OR=6.04,95%CI:1.26-28.92)。与偶尔(OR=6.68,95%CI:0.37-119.59;OR=106.31,95%CI:3.41-3313.30)和每日(OR=57.49,95%CI:2.37-1396.46;OR=170.99,95%CI:4.61-6339.47)使用者相比,大麻和抑郁的使用增加了非可卡因使用者海洛因戒除的可能性。
一般模型中的大多数预测因子仅在丁丙诺啡模型中具有统计学意义,而在美沙酮模型中则没有,这表明一般模型的预测价值有限。在所有模型中,可卡因使用均是随访时海洛因戒除的重要预测因子,但对于丁丙诺啡,只有在存在抑郁或大麻使用时才是如此。需要进一步研究以评估针对不断增加的双重使用者群体的有效治疗方法。